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Abstract
Neuroligins are cell adhesion proteins that interact with neurexins at the synapse. This interaction may contribute to
differentiation, plasticity and specificity of synapses. In humans, single mutations in neuroligin encoding genes lead to
autism spectrum disorder and/or mental retardation. Caenorhabditis elegans mutants deficient in nlg-1, an orthologue of
human neuroligin genes, have defects in different behaviors. Here we show that the expression of human NLGN1 or rat
Nlgn1 cDNAs in C. elegans nlg-1 mutants rescues the fructose osmotic strength avoidance and gentle touch response
phenotypes. Two specific point mutations in NLGN3 and NLGN4 genes, involved in autistic spectrum disorder, were further
characterized in this experimental system. The R451C allele described in NLGN3, was analyzed with both human NLGN1
(R453C) and worm NLG-1 (R437C) proteins, and both were not functional in rescuing the osmotic avoidance behavior and
the gentle touch response phenotype. The D396X allele described in NLGN4, which produces a truncated protein, was
studied with human NLGN1 (D432X) and they did not rescue any of the behavioral phenotypes analyzed. In addition, RNAi
feeding experiments measuring gentle touch response in wild type strain and worms expressing SID-1 in neurons (which
increases the response to dsRNA), both fed with bacteria expressing dsRNA for nlg-1, provided evidence for a postsynaptic
in vivo function of neuroligins both in muscle cells and neurons, equivalent to that proposed in mammals. This finding was
further confirmed generating transgenic nlg-1 deficient mutants expressing NLG-1 under pan-neuronal (nrx-1) or pan-
muscular (myo-3) specific promoters. All these results suggest that the nematode could be used as an in vivo model for
studying particular synaptic mechanisms with proteins orthologues of humans involved in pervasive developmental
disorders.
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Introduction
Animal social interactions, learning experiences and behaviour-
al responses to a wide range of environmental stimuli are
fundamentally underpinned by the connectivity between nerve
cells at synapses. The synapses act in circuits which serve to
integrate and compute an extraordinary complex network of
inputs. Behavior is the result of the interaction of a set of varying
stimuli with an extraordinary complex network of nervous and
muscle cells. Several lines of evidence suggest that the alteration of
neuron connections during development of the nervous system
may constitute the basis of pervasive developmental disorders
[1,2]. Neuroligins are postsynaptic cell adhesion proteins that
interact with neurexin at the synapse [3,4]. Both neuroligins and
neurexins were shown to induce synaptogenesis [5–7], and it has
been proposed that the interactions between different isoforms
contribute to differentiation and specificity of synapses [8,9]. Most
mammals have four neuroligin genes (NLGN1-4) [10–12] while
humans have a fifth gene in the Y chromosome (NLGN4Y) [13]. All
neuroligins share a similar structure with a large extracellular
cholinesterase-like domain, a transmembrane region, and a short
cytoplasmic tail [14]. In the vertebrate central nervous system,
neuroligins are preferentially localized at postsynaptic sites where
they assemble as a dimer, linking two subunits through a tightly
packed four-helix bundle of two helices from each subunit [15].
The neurexin/neuroligin adhesion system of synapses is highly
conserved in the animal kingdom and although gene number and
isoforms vary among vertebrates and invertebrates, these adhesion
complexes seems to be conserved throughout evolution [16]. In
humans it has been shown that single missense and frameshift
mutations in neuroligin genes lead to autism and/or mental
retardation with complete penetrance [17–21].
The C. elegans nlg-1 gene is orthologous to mammalian
neuroligin genes. The protein encoded by nlg-1 is similar to other
neuroligin proteins, because it conserves the structure of the major
domains, including the large extracellular cholinesterase-like
domain, a type-1 transmembrane protein sequence and an
intracellular domain with a PDZ-binding motif at the C-terminal
end [22]. The nlg-1 gene is expressed throughout the C. elegans
nervous system, including around 20 neurons of the head, 20
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39277
neurons in the ventral nerve cord and in the body wall of some
muscle cells [22]. As in vertebrates, NLG-1 is located at dendritic
postsynaptic sites, although it is also expressed in presynaptic
regions of some types of neurons [23]. The gene covers about 6 Kb
in the nematode genome, and as many as 24 NLG-1 isoforms have
been predicted as consequence of alternative splicing nlg-1 [22].
The nlg-1 deficient mutants are defective in sensory behavior
affecting various neuronal circuitries [22,24]. In addition, sensi-
tivity to oxidative agents such as paraquat and copper, as well as
intolerance to mercury, was much higher in nlg-1-mutants than in
wild-type animals [22].
In this study we show that two behaviors impaired in nlg-1
deficient mutants, fructose osmotic strength avoidance [25] and
gentle touch response (identified in this work), are rescued by
transgenic expression of cDNA from human NLGN1 or rat Nlgn1
genes, demostrating that these mammalian neuroligins are
functional in the nematode. Our results suggest that C. elegans
can be used as an in vivo model for the study of specific human
genes, and open the way for the analysis of molecular mechanisms
involved in synaptic activities involved in complex human
neurological disorders.
Results
Generation of transgenic strain expressing worm NLG-1,
human NLGN1 and rat Nlgn1 in neuroligin deficient
mutants of C. elegans
To test whether mammalian neuroligins were able to rescue the
behavioral phenotype of neuroligin deficient mutants of C. elegans,
we generated translational constructs with the nlg-1 promoter
driving the human NLGN1 cDNA (Kazuza DNA Research
Institute, Japan), the rat Nlgn1-EGFP construct [26,27] and as a
positive control the worm nlg-1 cDNA (National Institute of
Genetics, Mishima, Japan).
A set of transgenic strains were produced by coinjecting the
plasmid carrying the human NLGN-1 or worm nlg-1 cDNAs under
control of the nlg-1 promoter, together with a plasmid conferring
resistance to neomicine as a selection marker which expressed GFP
under control of the myo-2 promoter as an additional transformation
marker [28]. Other transgenic strains expressing the human NLGN-
1 were obtained by coinjecting the plasmid with NLGN-1 cDNA
under the nlg-1 promoter and a plasmid expressing GFP driven by
the promoter of nrx-1 as a transformation marker [28]. The worm
nrx-1 gene encodes an orthologue of vertebrate neurexins, that is
expressed in most cells of the nervous system [29].
Several lines of worm expressing the rat Nlgn1-EGFP cDNA
were obtained by coninjecting a plasmid harboring this cDNA
driven by the nlg-1 gene promoter together with a plasmid
conferring resistance to neomycin [28].
In order to select the transformed worms expressing human or
rat NLGN1 for phenotypic analysis, transgenic animals were
analyzed under the microscope to monitor GFP or EGFP
expression. Figure S1 illustrates the expression of GFP and EGFP
under the nrx-1 and nlg-1 gene promoters respectively. The
expression pattern observed in head ganglia and ventral nerve
cord was similar to that reported previously for neurexin [29] and
neuroligin [22] genes in the worm.
Human NLGN1 and rat Nlgn1 cDNAs rescue the mutant
phenotype in nlg-1 defective mutants of C. elegans for
the response to 4M fructose solution
C. elegans has developed mechanisms to avoid hyperosmotic
environments such as high concentration of salts or sugars [30,31].
We have previously shown that nlg-1 deficient mutants are impaired
in the capacity to detect a 4M fructose solution [24,25]. Figure 1A
shows that the average percentage of response to the osmotic barrier
for Bristol N2 wild type strain was 9567%. This response is notably
much higher than 2565 % presented by the nlg-1 deficient strain
carrying the allele ok259. Figure 1A also shows that transgenic
expression in the nlg-1(ok259) deficient mutant of cDNAs from C.
elegans nlg-1, human NLGN1 or rat Nlgn1, all driven by the C. elegans
nlg-1 promoter, rescued the mutant phenotype. Percentage
responses in these transgenic strains were 7966% for worm nlg-1
cDNA, 6665% and 6865% for human NLGN1 cDNA (strains
CRR103 and CRR106 respectively), and 6165% for rat Nlgn1
cDNA (strain CRR109). Two negative controls consisting of a nlg-
1(ok259) mutant harboring an empty vector (strain CRR100) and a
strain derived from CRR106 that spontaneously lost the array
containing GFP and the humanNLGN1 cDNA, presented percentage
responses similar to those of the nlg-1 (ok259) mutant (1962% and
2962%, respectively, Figure 1A).
The first two mutations involved in autism spectrum disorder
identified in genes encoding neuroligins were a C to T transversion
in NLGN3, which originated an Arg451Cys change, and a T
insertion in NLGN4 that generated an Asp396X stop codon [17].
Arg451 (NLGN3) is conserved both in worm NLG-1 (Arg437 site)
and human NLGN1 (Arg453 site) proteins (Figure S2). Asp396 of
NLGN4 is conserved in human NLGN1 and corresponds to the
Asp432 site (Figure S2). Figure 1B shows the percentage responses
to 4M fructose barrier of nlg-1(ok259) deficient mutant expressing
cDNAs of the C. elegans nlg-1 allele encoding a protein with
Arg437Cys (CRR105 strain), or human NLGN1 allele encoding
proteins with Arg453Cys (CRR107 strain) and Asp432X
(CRR108 strain) changes. While the CRR105 strain showed a
clear reduced response to the 4M fructose barrier compared to the
CRR104 strain (3666% versus 7966%), CRR107 strain only
show a slight significant difference (P = 0.014) with its control
partner CRR103 strain (5360.06% versus 6665%). On the other
hand the CRR108 transgenic strain, with the NLGN1 (Asp432X)
truncated protein has a similar response to the CRR1 nlg-1(ok259)
strain (4164% versus 3464%) (Figure 1B).
Human NLGN1 and rat Nlgn1 cDNAs rescue the mutant
phenotype for gentle touch response in nlg-1 defective
mutants of C. elegans
The sense of gentle touch is based on the capability of some
sensory cells of C. elegans to translate mechanical inputs into ionic
currents which activate a neural circuit that drives a locomotory
response [32]. When the nematode receives a tactile stimulus with an
eyebrow hair in the anterior or posterior part of its body, it changes
the direction of motion inducing movement back or forward
respectively [33]. Figure 2 shows that the neuroligin deficient
mutant nlg-1(ok259) loses a significant capability of the mechano-
sensory response in both the anterior and posterior part of the body
with respect to the wild type strain. Transgenic expression in the nlg-
1(ok259) deficient mutant of cDNAs from C. elegans nlg-1, human
NLGN1 or rat Nlgn1, all driven by the C. elegans nlg-1 promoter,
rescued the mutant phenotype (Figure 2), whereas expression of
cDNAs from worm nlg-1 Arg437Cys or human NLGN1 Arg453Cys
alleles did not. The transgenic nlg-1(ok259) deficient mutants
harboring an empty vector or with a human truncated NLGN1
allele (Asp432X) were used as negative controls.
When C. elegans is stimulated repeatedly with an eyebrow hair
(gentle touch), the stimulus fails to produce a response and the
animal become refractory [33]. Figure 3 shows that the wild type
strain responds five times consecutively to gentle touch in the
anterior and posterior parts of the body, whereas the neuroligin
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deficient strain nlg-1(ok259) fails to respond almost completely to
the fourth and fifth touch. Transgenic expression of cDNAs from
C. elegans nlg-1, human NLGN1 or rat Nlgn1, all driven by the C.
elegans nlg-1 promoter, in the nlg-1(ok259) deficient mutant,
partially rescued the mutant phenotype, while the cDNAs from
worm nlg-1 Arg437Cys or human NLGN1 Arg453Cys alleles
failed to rescue the response to the fourth and fifth gentle touch
(Figure 3). As negative controls, the transgenic nlg-1(ok259)
deficient mutants harboring an empty vector or with a human
truncated NLGN1 allele (Asp432X) were used.
Specific expression of worm NLG-1 in neuron and muscle
cells, and nlg-1 RNAi bacterial feeding experiments
indicate that neuroligin potentiates, but is not essential
for, gentle touch response
Feeding RNAi is efficient in virtually all C. elegans cells except
neurons [34]. We analized the effect of nlg-1 RNAi bacterial
feeding on the gentle touch response phenotype (Figure 4). N2
strain fed with bacteria containing plasmid pL4440 expressing nlg-
1 dsRNA showed a significant decrease in the response to gentle
touch respect to control fed with bacteria with empty plasmid,
providing evidence for a postsynaptic in vivo function of neuroligins
in muscle cells of C. elegans. However, this decrease did not equal
the values obtained in nlg-1 (ok259) deficient strain (Figure 4),
indicating that neuroligin expressed in neurons also might play a
role in gentle touch response. To verify this possibility, we replicate
these experiments with the strain TU3335 which specifically
express the transmembrane protein SID1 in the nervous cells.
SID1 has been proposed to function as a channel for the transport
of dsRNA [35], increasing the response to dsRNA delivered by
feeding [36]. As shown in Figure 4, RNAi feeding of the TU3335
strain grown on bacteria expressing the nlg-1 dsRNA fragment
produced a similar response to gentle touch that N2 control strain.
This result contrast with a control consisting of worms fed with
bacteria expressing dsRNA for mec-4, a gene expressed exclusively
in neurons required for the gentle touch response [32]. These
findings suggest that the effect of the deficiency of nlg-1 in gentle
touch depends on the expression of NLG-1 in both muscular and
neuronal cells.
To further verify the functional role in vivo of neuroligin in
neurons and/or muscle cells, we generated transgenic nlg-1
deficient mutants expressing nlg-1 gene under pan-neuronal (nrx-
Figure 1. Expression of human NLGN1 and rat Nlgn1 cDNAs rescue the osmotic strength response in nlg-1 defective mutants of C.
elegans. Percentages of osmotic avoidance to 4M fructose solution of wild type N2, nlg-1(ok259) and different transgenic strains are illustrated. (A)
Rescues: Worm nlg-1 correspond to CRR104 transgenic strain (crrEx4 [pPD95.77 (Pnlg-1::nlg-1); pDD04NeoR (Pmyo-2::GFP)]); Human NLGN1 (1) and (2)
represent transgenic strains CRR103 (crrEx3 [pPD95.77 (Pnlg-1::NLGN1); pDD04NeoR (pmyo-2::GFP)]) and CRR106 (crrEx6 [pPD95.77 (Pnlg-1::NLGN1);
nrx-1::GFP]); Rat Nlgn1 correspond to transgenic strain CRR109 (crrEx9 [pPD95.77 (Pnlg-1::Nlgn1::EGFP); pBCN24NeoR]). Controls are CRR100 transgenic
strain containing the pDD04NeoR empty vector, and a strain derived from CRR106 that spontaneously lost the array with GFP and human NLGN1
cDNA. (B) Rescues: Worm nlg-1 is CRR104 strain as above; Worm nlg-1 R437C is CRR105 strain (crrEx5 [pPD95.77 (Pnlg-1::nlg-1-R437C); pDD04NeoR
(Pmyo-2::GFP)]); Human NLGN1 is CRR103 as above; Human NLGN1 R453C is CRR107 strain (crrEx7 [pPD95.77 (Pnlg-1::NLGN1-R453C); pDD04NeoR
(Pmyo-2::GFP)]); Human NLGN1 D396X is CRR108 (crrEx8 [pPD95.77 (Pnlg-1::NLGN1-D396X); pDD04NeoR (Pmyo-2::GFP)]). At least three different
experiments were carried out with each strain (approximately 50 worms per experiment). In the case of the strain CRR107, six experiments were
performed. Error bars indicate the SEM. The asterisk indicates significant differences (p#0.001) (*
a indicates P = 0.014) calculated by ANOVA/Fisher’s
test.
doi:10.1371/journal.pone.0039277.g001
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1) or pan-muscular (myo-3) specific promoters. Figure 5 shows that
both transgenic strains were able to rescue significantly the gentle
touch response respect to the nlg-1 deficient mutant, results that
are in agreement with the RNAi bacterial feeding assays;
indicating that neuroligin are necessary not only in postsynaptic
neuromuscular junction but also in general postsynaptic neuronal
wiring. These experiments together with the fact that the nlg-1
deficient mutant is not completely defective in gentle touch
response (Figures 4 and 5) suggest that neuroligin potentiates, but
is not essential for, gentle touch response.
Discussion
Animals are able to detect a wide range of environmental
conditions by means of sensory neurons. An unusual feature of these
neurons is that they are often polymodal and can respond to distinct
types of stimuli. C. elegans sensory neurons can express multiple
GPCRs in the same nerve cell, allowing the nematode to respond
specifically to different environmental conditions using only a few
neurons [37]. For this reason, one would expect that mutations in
genes encoding proteins involved in a wide range of interaction
mechanisms between nerve cells should cause defects in numerous
behavioral responses. This is the case of neuroligin, a synapse
adhesion molecule conserved widely in the animal kingdom [8].
Thus, C. elegans mutants deficient in neuroligin were defective in a
subset of behaviors and showed hypersensitity to oxidative stress and
mercury [22]. The neuroligin deficient mutants were also impaired
in the processing of sensory inputs related to the detection of osmotic
strength, and failed to consistently detect a 4M fructose solution
[24,25]. Moreover, nlg-1 deficient mutants are impaired in gentle
touch response (Figure 2), and repeated mechanic stimulation with
an eyebrow hair led to a reduction in the magnitude of the sensory
response in these mutants (Figure 3). These observations indicate
that neuroligins are necessary for correct and full overall synapse
functionality.
Expression of human NLGN1 and rat Nlgn1 isoforms in
neuroligin deficient mutants of the nematode showed that both
were able to rescue specific behavioral phenotypes such as osmotic
avoidance and gentle touch responses. This observation is to some
extent expected, given the homology between these proteins. In
fact, NLG-1 from C. elegans, which has an estimated size of 847
amino acids, shows around 28% identity and 44% similarity with
the extracellular cholinesterase-like domain of human NLGN1
and rat Nlgn1 proteins (Table S1). The type I transmembrane
domain and the intracellular sequence containing the PDZ
binding motif, also have significant identity and similarity
percentages (Table S1). Furthermore, worm transmembrane
Figure 2. Expression of human NLGN1 and rat Nlgn1 cDNAs rescue the wild type phenotype for gentle touch response in nlg-1
defective mutants of C. elegans. Data are quantified as percentage of positive response to gentle touch. Animals were touched ten times,
alternating anterior and posterior part of the body. The measure was carried out by stroking an eyebrow hair across the body just behind the pharynx
for the anterior touch response (A), or just before the anus for the posterior touch response (B). Rescues: Worm nlg-1 correspond to CRR104
transgenic strain (crrEx4 [pPD95.77 (Pnlg-1::nlg-1); pDD04NeoR (Pmyo-2::GFP)]); Human NLGN1 represent transgenic strains CRR103 (crrEx3 [pPD95.77
(Pnlg-1::NLGN1); pDD04NeoR (pmyo-2::GFP)]); Rat Nlgn1 correspond to transgenic strain CRR109 (crrEx9 [pPD95.77 (Pnlg-1::Nlgn1::EGFP);
pBCN24NeoR]); Worm nlg-1 R437C is CRR105 strain (crrEx5 [pPD95.77 (Pnlg-1::nlg-1-R437C); pDD04NeoR (Pmyo-2::GFP)]); Human NLGN1 R453C is
CRR107 strain (crrEx7 [pPD95.77 (Pnlg-1::NLGN1-R453C); pDD04NeoR (Pmyo-2::GFP)]); Human NLGN1 D396X is CRR108 (crrEx8 [pPD95.77 (Pnlg-
1::NLGN1-D396X); pDD04NeoR (Pmyo-2::GFP)]). Control is CRR100 a transgenic strain containing the pDD04NeoR ‘‘empty vector’’. At least three
different experiments were carried out with each strain (approximately 50 worms per experiment). Error bars indicate the SEM. The asterisk indicates
significant differences (p#0.001) calculated by ANOVA/Fisher’s test.
doi:10.1371/journal.pone.0039277.g002
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proteins have been expressed successfully in human cells [38], and
also human transmembrane proteins have been expressed in C.
elegans [39], indicating that transmembrane domains from proteins
of both organisms are functional in either worm or human cell
membrane. The homology between mammalian and C. elegans
neuroligins is not only in terms of amino acid sequence, but also in
molecular structure. Using the FlexProt algorithm [40], the 3D
structural alignment of human NLGN1 and C. elegans NLG-1
proteins showed a analogous spatial functional domain configu-
ration (Figure S3).
It is interesting to note the responses of osmotic avoidance and
gentle touch of transgenic strains harboring R437C and R453C
mutations in worm and human NLG-1 and NLGN1 proteins,
respectively. The R451C change in NLGN3, which has been
related to autism spectrum disorder [17], was shown to cause the
retention of the protein in the endoplasmic reticulum [41]. The
lack of rescue by NLG-1 with the R437C change may have a
different cause, since when there is a mutation R451C in NLG-1,
two beta-sheets with a greater length between residues 542 and
557 are formed (Figure S4). This could involve a modification in
the secondary structure of alpha helix25-beta sheet15-beta harpin-
beta sheet16 set, causing a total or partial destabilization of the
Ca2+ binding site that is necessary for the interaction of neuroligin
with neurexins [42]. In the case of human NLGN1, the change
R451C did not show any apparent modification in the hypothet-
ical model of protein structure.
The effect of nlg-1 RNAi bacterial feeding on the gentle touch
response phenotype (Figure 4), gives support for a postsynaptic in
vivo function of neuroligins both in muscle cells and neurons. This
idea was further confirm generating transgenic nlg-1 deficient
mutants expressing NLG-1 under pan-neuronal (nrx-1) or pan-
muscular (myo-3) specific promoters (Figure 5). These experiments
agree with previous results carried out in a genetic background
with a dysfunctional rrf-3 gene, encoding a putative RNA-directed
RNA polymerase, where there is an increase to RNAi sensitivity in
most neuron subtypes [43]. It was found that N2 wild type and a
rrf-3 (pk1436) strains fed with bacteria expressing a nlg-1 dsRNA
fragment, had a similar behavior with respect to the 4M fructose
osmotic avoidance phenotype than the mutation nlg-1(ok259) itself
[24,25]; suggesting that there was a contribution from NLG-1 in
Figure 3. Recovery of the wild type repeated gentle touch response by expression of human NLGN1 and rat Nlgn1 cDNAs in nlg-1
defective mutants of C. elegans. Data are quantified as percentage of positive responses to ten alternative gentle touches in the anterior (A) and
posterior (B) part of the body (five each). The genotypes of the strains used are shown in the legend of Figure 2. At least three different experiments
were carried out with each strain (approximately 50 worms per experiment). Error bars indicate the SEM. The asterisk indicates significant differences
(p#0.001) calculated by ANOVA/Fisher’s test.
doi:10.1371/journal.pone.0039277.g003
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Figure 4. Expression of sid-1 in neurons does not enhance the response to gentle touch by nlg-1 RNAi bacterial feeding. Bristol N2 and
TU3335 (Punc-119sid-1) strains were fed with bacteria carrying the pL4440 vector with RNAi targeting the nlg-1 and mec-4 genes, or with the empty
vector. Quantitative assays for touch sensitivity were carried out in the anterior (A) and posterior (B) parts of the body. The responses in these
knockdown animals were compared with the wild type and nlg-1 deficient mutants. At least three different experiments were carried out with each
strain (approximately 50 worms per experiment). Error bars indicate the SEM. The asterisk indicates significant differences (p#0.001) calculated by
ANOVA/Fisher’s test.
doi:10.1371/journal.pone.0039277.g004
Figure 5. Gentle touch response in transgenic nlg-1 deficient strains expressing NLG-1 under pan-neuronal (nrx-1) or pan-muscular
(myo-3) specific promoters. Quantitative assays for touch sensitivity were carried out in the anterior (A) and posterior (B) parts of the body (see
legend to Figure 2). The responses in the transgenic animals were compared with the N2 wild type and nlg-1 (ok259) deficient mutants. Pnrx-1::nlg-1
correspond to strains CRR110 nlg-1 (ok259) X; crrEx10 [pPD95.77 (Pnrx-1::nlg-1); pDD04NeoR (Pmyo-2::GFP)], and Pmyo3::nlg-1 correspond to strain
CRR111 nlg-1 (ok259) X; crrEx11[pPD95.77 (Pmyo-3::nlg-1); pDD04NeoR (Pmyo-2::GFP)]. At least three different experiments were carried out with each
strain (approximately 50 worms per experiment). Error bars indicate the SEM. The asterisk indicates significant differences (p#0.001) calculated by
ANOVA/Fisher’s test.
doi:10.1371/journal.pone.0039277.g005
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both neuronal and muscle cell to this behaviour. These overall
results suggest that neuroligin potentiates, but is not essential for
many of the behavioural phenotypes impaired in nlg-1 deficient
mutants, which explain the viability of these defective strains.
Our results imply that C. elegans represents a useful in vivo genetic
model for studying the role of neuroligins in basic mechanistic
pathways involved in complex human neurological disorders. The
nematode can be used both as a model for studying the behaviour
of mutants defective in nlg-1 and as an organism that allows
transgenic and functional expression of mammalian neuroligins.
The fact that C. elegans constitutes a well-characterized system in
which neuronal development can be followed simultaneously with
molecular and behavioral phenotype analysis, facilitates the
analysis of how mutations in neuroligin genes modulate pheno-
types in different genetic backgrounds and under different
environmental conditions.
Materials and Methods
Strains and maintenance
All nematodes were grown and maintained at 20uC under
standard conditions [44]. Table 1 shows the worm strains used in
this study. C. elegans and OP50 E. coli strains were obtained from
the Caenorhabditis Genetic Center (University of Minnesota,
Minneapolis, MN, USA) and the National BioResource Project
(Tokyo Women’s Medical College, Tokyo, Japan). Extrachromo-
somal arrays were generated by coinjecting ‘‘marker’’ (0.5 mg/mL)
and ‘‘rescue’’ (30–50 mg/mL) plasmids into the germ line of adult
hermaphrodites [45].
Cloning and transgenic methods
cDNA cloning of the C. elegans nlg-1 gene. Information
available at www.wormbase.org, identifies the C. elegans gene
C40C9.5 as encoding a neuroligin, with three different splices
variants named a, b and c respectively. C40C9.5 has been assigned
the name nlg-1. The genomic sequence of nlg-1 was used to design
the following specific primers, nlg-1forward 59-GCGAATTTGg-
gatccAACAGGCATG-39 and nlg-1resverse 59-GGGTGTgaatt-
cAAAAACTTGAATTG-39, to amplified by PCR the coding
region corresponding to transcript b from the cDNA clone
yk1657a10 (from Yuji Kohara, National Institute of Genetics,
Mishima, Japan). The promoter region of nlg-1 was amplified
using the Pnlg-1forward 59-TtctagaCATATTTTTGGG-
GAGGCTTTC-39 and Pnlg-1reverse 59-GAAGGAGAAGAAGA-
TAAATGggatccATGC-39 from the C40C9 cosmid clon (from
Sanger Institute, UK).
cDNA cloning of NLGN1 human gene. NLGN-1 genomic
sequence was used to design the following specific primers:
NLGN1forward 59-ATGTggatccCATGGCACTGCCC-39 and
NLGN1resverse 59-AAAAATAGTTTgaattcTCTTATCTGGC-
39. These primers were used to amplify by PCR, the coding
region from the cDNA clone KIAA1070 (hj05602) (obtained from
Kazusa DNA Research Institute, Japan).
cDNA cloning of Nlgn1 rat gene. cDNA cloning of Nlgn1-
EGFP was carried out after BglII-BamHI digestion of pCMV5
vector, that was a gift from Thomas Dresbach [26,27]. The
digestion product was cloned into pPD95.77 vector.
Rescue constructions and transgenic
methods. Translational constructions were obtained by fusing
nlg-1, NLGN1 or Nlgn1-EGFP cDNAs with the nlg-1, nrx-1 or myo-3
promoters, using the XbaI/BamHI site in the pDD95.77 vector. The
promoter region of nrx-1 was amplified using the Pnrx-1forward 59-
Table 1. C. elegans strains used in this study
Strain name Genotype Source
N2 Wild type, DR subclone of CB original CGCa
VC228 nlg-1 (ok259) X CGC
FX00474 nlg-1 (tm474) X NBPb
TU3335 lin-15B(n744) X; uIs57 [unc-119p::YFP + unc-119p::sid-1 + mec-6p::mec-6] CGC
CRR1c nlg-1 (ok259) X This study
CRR2d nlg-1 (tm474) X This study
CRR100 nlg-1 (ok259) X; crrEx4 [pPD95.77; pDD04 NeoR (Pmyo-2::GFP)] This study
CRR103 nlg-1 (ok259) X; crrEx3 [pPD95.77 (Pnlg-1::NLGN-1); pDD04NeoR (Pmyo-2::GFP)] This study
CRR104e nlg-1 (ok259) X; crrEx4 [pPD95.77 (Pnlg-1::nlg-1); pDD04NeoR (Pmyo-2::GFP)] This study
CRR105 nlg-1 (ok259) X; crrEx5 [pPD95.77 (Pnlg-1::nlg-1-R437C); pDD04NeoR (Pmyo-2::GFP)] This study
CRR106f nlg-1 (ok259) X; crrEx6 [pPD95.77 (Pnlg-1::NLGN1); Pnrx-1::GFP] This study
CRR107 nlg-1 (ok259) X; crrEx7 [pPD95.77 (Pnlg-1::NLGN1-R453C); pDD04NeoR (Pmyo-2::GFP)] This study
CRR108 nlg-1 (ok259) X; crrEx8 [pPD95.77 (Pnlg-1::NLGN1-D396X); pDD04NeoR (Pmyo-2::GFP)] This study
CRR109g nlg-1 (ok259) X; crrEx9 [pPD95.77 (Pnlg-1::Nlgn1::EGFP); pBCN24NeoR] This study
CRR110 nlg-1 (ok259) X; crrEx10 [pPD95.77 (Pnrx-1::nlg-1); pDD04NeoR (Pmyo-2::GFP)] This study
CRR111 nlg-1 (ok259) X; crrEx11[pPD95.77 (Pmyo-3::nlg-1); pDD04NeoR (Pmyo-2::GFP)] This study
aCaenorhabditis Genetics Center.
bNational BioResource Project.
cAfter outcrossing VC228 strain with N2 at least six times.
dAfter outcrossing FX00474 strain with N2 at least six times.
eThe cDNA nlg-1 coding region was obtained from clone yk1657a10 from Yuji Kohara, National Institute of Genetics, Mishima, Japan.
fThe cDNA human NLGN1 coding region was obtained from clone KIAA1070 (hj05602), Kazusa DNA Research Institute, Japan.
gRat Nlgn-1::EGFP was a gift from Dr. Thomas Dresbach, Univ. Go¨ttingen, Germany.
doi:10.1371/journal.pone.0039277.t001
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ACATTTTTAAACAtctagaTTTCTAGG-39 and Pnrx-1reverse
59- CGTTAAGTATGGTCCAggatccATCAAAC-39 from
C29A12 cosmid clon (from Sanger Institute, UK). The myo-3
promoter was obtained from pPD133.54 [46].VC228 nlg-1 (ok259)
X animals were microinjected with nlg-1, NLGN1 and Nlgn1-EGFP
‘‘rescue’’ constructions together with the ‘‘marker’’ plasmids
pDD04NeoR, pDD04NeoR (Pmyo-2::GFP) or pDD95.77 (Pnrx-
1::GFP).
Microscopy and imaging
For precise imaging of GFP fluorescence in the nervous system,
a Leica DM 5000B microscope was used. Worms were put into
0.5 mL M9 buffer on a thin 2% agarose pad containing an
anesthetic (10 mM levamisole), and were monitored with a 40–
63X objective magnification. Worms were observed with a DIC
optical system, or in the 395 or 615 nm channel for fluorescence.
Images were acquired through a Leica IM50 4.0 camera software,
and were cropped to size, assembled, and processed using Abode
PhotoShopH software.
Behavioral assays
The behavioral experiments were carried out with two strains
deficient in nlg-1 gene, CRR1 (ok259) and CRR2 (tm474). The
phenotype of strains with ok259 allele was assessed in more detail,
and the strain with tm474 allele was assayed to confirm that they
shared similar phenotypes. In all the behavioral experiments, at
least two different lines of each transgenic strain were analyzed to
check if they showed similar phenotypes.
Osmotic avoidance assay. The assay was performed as was
described previously in Calahorro et al. [24]. Briefly, C. elegans L4
animals of each strain were placed within an annular ring (1 cm
diameter) of 4 M fructose solution, on NGM plates. Wild-type
animals typically avoid the ring six times in succession. Worms
failing to avoid the ring six times consecutively were scored as non-
avoiders. The data were expressed as percentage of worms
responding to the osmotic barrier.
Gentle touch assay. This phenotype was tested by stroking
ten times the worm with an eyebrow hair attached to a toothpick,
alternating the anterior (just behind the pharynx) and posterior
(just before the anus) part of the body. A positive response causes
the animal to move backward or forward respectively [33,47].
Bacterial feeding RNA interference assay
N2 Bristol and TU3335 C. elegans strains were use for RNAi
experiments (Table 1). HT115 E.coli strain (DE3) with plasmid
pL4440 carrying nlg-1 (JA:C40C9.5) and mec4 (TO1C8.7) gene
fragments were provided by Peter Askjaer, Centro Andaluz de
Biologı´a del Desarrollo (CABD), Sevilla, Spain, and Julia´n Cero´n,
Bellvitge Institute for Biomedical Research (IDIBELL) Barcelona,
Spain, respectively. Worms were fed on standard agar plates
supplemented with carbenicillin (50 mg/mL-1) and 1 mM IPTG
to induce dsRNA production. HT-115 transformed with the
empty pL4440, pL4440/unc-22 (from Peter Askjaer) and pL4440/
gfp (from Julia´n Cero´n) constructs were also used as controls.
Supporting Information
Figure S1 GFP or EGFP fluorescence in transgenic
strains expressing worm NLG-1, human NLGN1 or rat
Nlgn1 cDNAs in neuroligin deficient mutants of C.
elegans. (A): Expression of GFP in neurons of head ganglia (a)
and ventral nerve cord (b) in strain crrEx6 [pPD95.77 (Pnlg-
1::NLGN1); Pnrx-1::GFP]. (B): Expression of EGFP in neurons of
head ganglia (a) and ventral nerve cord (b) in strain (crrEx9
[pPD95.77 (Pnlg-1::Nlgn1::EGFP); pBCN24NeoR]). In A (a) and B
(a), the images correspond to DIC (above), epifluoresce (middle)
and merge (below), respectively. In A (b) and B (b) the images
correspond to dorsal nerve cord (above) and ventral nerve cord
(below). Scale bars are 15 mm. Arrowheads in A (b) indicate the
position of body cell of each motorneuron. Asterisks indicate
autofluorescence signal.
(TIF)
Figure S2 Comparative amino acid sequences of C.
elegans and human neuroligins within the acetylcholine-
like domain, showing the conserved residues involved in
autism spectrum disorder: Arg (R) in NLGN3 and Asp
(D) in NLGN4. The red boxes mark the residues R and D. R is
conserved in human and worm neuroligins, and D only in
humans. Identical residues are indicated by black boxes and
similar residues are shaded in grey. The alignment of protein
sequences was performed using the Clustal W method.
(TIF)
Figure S3 3D structural alignment for C. elegans NLG-1
and human NLGN1 proteins. Alignment of the carbon
skeletons for C. elegans NLG-1 protein (blue) and human NLGN1
(red) proteins is shown. RMSD (Root Mean Square Deviation)
parameter was calculated using FlexProt bioinformatics suite [40].
Values for back-bone length, number of flexible regions, match
size and matched rigid fragments between both proteins are
shown. RMSD =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
N
Xi~N
i~1
s2i
vuut ; where s is the distance between N
pairs of equivalent Ca.
(TIF)
Figure S4 Hypothetical models of NLG-1 protein of C.
elegans. Wild type NLG-1 protein (A) and with the Arg451Cys
change (B) three-dimensional models, are shown. In B, the black
arrow indicates the conformational change produced by the
R451C mutation, and the white arrow marks the position of a
he´lix. C, shows details of the secondary structure modification in
the b sheets 15 and 16 within the 544–557 residues sequence of the
protein; thus, the R451C generates longer b sheets between
residues 543–557 (black arrow in B). Both models were powered
by Swiss-Model Proteomic Serve [48–50].
(TIF)
Table S1 Identity and similarity percentage between C. elegans
NLG-1 and human and rat NLGN1 proteinsa.
(DOC)
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